Comparison of antiallergic drugs in an experimental model of ocular anaphylaxis

Ophthalmologica

Volumn 217, Issue 2, 2003, Pages 119-123

  Bayer, Atilla ^a   Uludaǧ, H Avni ^b   Sobaci, Güngör ^a   Mutlu, Fatih Mehmet ^a  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

^b Erzurum State Hospital   (Turkey)

Author keywords

Antiallergic drugs; Experimental anaphylaxis model; Rat

Indexed keywords

CIMETIDINE; CROMOGLYCATE DISODIUM; DICLOFENAC; DITHIOTHREITOL; EVANS BLUE; LEVOCABASTINE; LODOXAMIDE; OVALBUMIN;

ANAPHYLAXIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL PERMEABILITY; COMPARATIVE STUDY; CONTRAST MEDIUM EXTRAVASATION; CONTROLLED STUDY; DISEASE MODEL; DRUG EFFICACY; EYE DISEASE; HISTOPATHOLOGY; IMMUNIZATION; INOCULATION; MALE; NONHUMAN; RAT; SPECTROPHOTOMETRY; STATISTICAL SIGNIFICANCE;

ANAPHYLAXIS; ANIMALS; ANTI-ALLERGIC AGENTS; CAPILLARY PERMEABILITY; CONJUNCTIVA; CONJUNCTIVITIS, ALLERGIC; DISEASE MODELS, ANIMAL; DITHIOTHREITOL; MALE; OPHTHALMIC SOLUTIONS; OVALBUMIN; RATS; RATS, WISTAR;

EID: 0344520478     PISSN: 00303755     EISSN: None     Source Type: Journal    
DOI: 10.1159/000068551     Document Type: Article

References (22)

1. Caldwell DR, Verin P, Young RH, Meyer SM, Drake MM: Efficacy and safety of lodoxamide 0.1% vs cromolyn sodium in patients with vernal keratoconjunctivitis. Am J Ophthalmol 1992;113:632-637.
2. Foster CS, Duncan J: Randomized clinical trial of topically administered cromolyn sodium for vernal keratoconjunctivitis. Am J Ophthalmol 1980;90:175-181.
3. Santos CI, Huang AJ, Abelson MB, Foster CS, Friedleander M, McCulley JP: Efficacy of lodoxamide 0.1% ophthalmic solution in resolving corneal epitheliopathy associated with vernal keratoconjunctivitis. Am J Ophthalmol 1994;117:488-497.
4. Ballas Z, Blumenthal M, Tinkelman DG, Kriz R, Rupp G: Clinical evaluation of ketorolac tromethamine 0.5% ophthalmic solution for the treatment of seasonal allergic conjunctivitis. Surv Ophthalmol 1993;38:141-148.
5. Harada M, Takeuchi M, Fukao T, Katagiri K: A simple method for the quantitative extraction of dye extravasated into the skin. J Pharm Pharmacol 1971;23:218-219.
6. Doherty MJ, Easty DL: Inflammatory and immunological cell profiles in a rat model of conjunctival immediate hypersensitivity. Clin Exp Allergy 1989;19:449-455.
7. Stockwell A, Easy DL: Group comparative trial of 2% nedocromil sodium with placebo in the treatment of seasonal allergic conjunctivitis. Eur J Ophthalmol 1994;4:19-23.
8. Trocme SD, Trocme MC, Bloch KJ, Allan-smith MR: Topically induced ocular anaphylaxis in rats immunized with egg albumin. Ophthalmic Res 1986;18:68-74.
9. Allansmith MR, Baird RS: Percentage of de-granulated mast cells in vernal conjunctivitis and giant papillary conjunctivitis associated with contactlens wear. Am J Ophthalmol 1981;91:71-75.
10. Bartlett JD: Pharmacology of allergic disease. J Am Optom Assoc 1990;61:S23-S31.
11. Yanni JM, Weimer LK, Glasser RL, Lang LS: Effect of lodoxamide on in vitro and in vivo conjunctival immediate hypersensitivity responses in rats. Int Arch Allergy Immunol 1993;101:102-106.
12. Abelson MB, Udell IJ, Allansmith MR, Raizman RB: Allergic and toxic reactions; in Albert DM, Jacobiec FA (eds): Principles and Practice of Ophthalmolgy: Clinical Practice. Philadelphia, WB Saunders,1994, vol 1, p 79.
13. Calonge MC, Pastor JC, Herreras JM, Gonzales JL: Pharmacologic modulation of vascular permeability in ocular allergy in the rat. Invest Ophthalmol Vis Sci 1990;31:176-180.
14. Güler M, Ceviz A, Ilker SS, Sobaci G, Yildirim E: Comparison of the efficacy of topical lodoxamide with sodium cromoglycate and dexamethasone sodium phosphate on passive allergic conjunctivitis model of rabbits. Bull 19th Turk Ophthalmol Soc Congr, Antalya, 1995.
15. Khosravi E, Elena PP, Hariton C: Allergic conjunctivitis and uveitis models: Reappraisal with some marketed drugs. Inflamm Res 1995; 44:47-54.
16. Kamei C, Izushi K, Tasaka K: Inhibitory effect of levocabastine on experimental allergic conjunctivitis in guinea pigs. J Pharmacobio-Dynam 1991;14:467-473.
17. 2 receptors in the human ocular surface. Arch Ophthalmol 1981; 99:302-304.
18. Leon J, Caharap A, Duzman E, Shen C: Efficacy of cimetidine/pyrilamine eye drops, a dose response study with histamin challenge. Ophthalmology 1986;93:120-123.
19. Woodward DF, Ledgard SE, Nieves AL: Conjunctival immediate hypersensitivity, re-evaluation of histamine involvement in the vasoper-meability response. Invest Ophthalmol Vis Sci 1986;27:57-63.
20. Koay P: The emerging roles of topical non-steroidal anti-inflammatory agents in ophthalmology. Br J Ophthalmol 1996;80:480-485.
21. Okada M, Shimada K: Effects of various pharmacologic agents on allergic inflammation of the eye. Invest Ophthalmol Vis Sci 1980;19:176-181.
22. Gary RK, Woodward DF, Nieves AL, Williams LS: Characterization of the conjunctival vasopermeability response to leukotrienes and their involvement in immediate hypersensitivity. Invest Ophthalmol Vis Sci 1988;29:1119-1126.